NCT04506112

Brief Summary

The study aims are to: 1) optimize the Transdiagnostic Sleep and Circadian Intervention (TranS-C) for delivery to Veterans in cardiac rehabilitation, 2) test and refine the adapted TranS-C treatment manual and protocol, and 3) conduct a pilot randomized trial to establish the feasibility, acceptability, and plausibility of the intervention protocol and study procedures.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 5, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 10, 2020

Completed
1.5 years until next milestone

Study Start

First participant enrolled

January 27, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 16, 2023

Completed
Last Updated

May 10, 2023

Status Verified

May 1, 2023

Enrollment Period

1.2 years

First QC Date

August 5, 2020

Last Update Submit

May 8, 2023

Conditions

Keywords

VeteransCardiac Rehabilitation

Outcome Measures

Primary Outcomes (5)

  • Multidimensional Treatment Satisfaction Measure

    Self-report measure of patient satisfaction with behavioral intervention process and outcomes. Subscale scores range from 0-4. Higher scores are suggestive of greater satisfaction with treatment.

    3 months

  • Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v 1.0-Sleep Disturbance 8a from Baseline to 3 and 6 months

    Validated self-report measure of global sleep disturbance over the preceding 7 days. Produces raw score and T-score values, where 50 is the mean of the reference population and 10 is the standard deviation. Higher scores are indicative of greater sleep disturbance.

    Baseline to 3 and 6 months

  • Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v 1.0-Sleep Related Impairment 8a from Baseline to 3 and 6 months

    Validated self-report measure of sleep-related impairment over the preceding 7 days. Produces raw score and T-score values, where 50 is the mean of the reference population and 10 is the standard deviation. Higher scores are indicative of greater sleep-related impairment.

    Baseline to 3 and 6 months

  • World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) from Baseline to 3 and 6 months

    Validated self-report measure of disability and functioning associated with physical and mental disorders. The WHODAS 2.0 contains 36-items that assess functioning in the domains of cognition, mobility, self-care, getting along, life activities, and participation over the preceding 30 days. The outcome of interest is the WHODAS 2.0 summary score. Using the complex scoring method, scores range from 0 to 100. Higher scores are indicative of greater disability.

    Baseline to 3 and 6 months

  • MacNew Heart Disease Health-Related Quality of Life Questionnaire (MacNew) from Baseline to 3 and 6 months

    Validated self-report measure of health-related quality of life in patients with heart disease. Contains 27 items that assess physical limitations, emotional function, social function, and symptoms common in heart disease (e.g., angina/chest pain, shortness of breath, fatigue, aching legs). The outcome of interest is the total health-related quality of life score. Scores range from 1 to 7. Higher scores are indicative of higher levels of health-related quality of life.

    Baseline to 3 months and 6 months

Secondary Outcomes (4)

  • Short Physical Performance Battery (SPPB) from Baseline to 3 and 6 months

    Baseline to 3 and 6 months

  • Physical Performance Test (PPT)from Baseline to 3 and 6 months

    Baseline to 3 and 6 months

  • Life Space Assessment from Baseline to 3 and 6 months

    Baseline to 3 and 6 months

  • World Health Organization Quality of Life-BREF (WHOQOL-BREF) from Baseline to 3 and 6 months

    Baseline to 3 and 6 months

Other Outcomes (2)

  • Pittsburgh Sleep Quality Index from Baseline to 3 and 6 months

    Baseline to 3 and 6 months

  • Insomnia Severity Index from Baseline to 3 and 6 months

    Baseline to 3 and 6 months

Study Arms (2)

TranS-C + Usual Care

EXPERIMENTAL

Participants in this group will receive TranS-C and will continue with care in cardiac rehabilitation as usual.

Behavioral: Transdiagnostic Sleep and Circadian Intervention (TranS-C), adapted for cardiac rehabilitation

Usual Care

NO INTERVENTION

Participants in this group will receive only usual care and thus will continue with care in cardiac rehabilitation as usual.

Interventions

Participants will complete the TranS-C intervention as adapted for cardiac rehabilitation. TranS-C is a behavioral intervention that is rooted in basic sleep and circadian science and draws from empirically-supported treatments including Cognitive Behavioral Therapy for Insomnia (CBT-I), Interpersonal and Social Rhythm Therapy (IPSRT), chronotherapy, and light therapy. It was designed to promote sleep health across a range of sleep problems. Participants in this group will also continue to receive care as usual, cardiac/sleep-related or otherwise.

Also known as: TranS-C
TranS-C + Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Veteran
  • Age 18 years or older
  • Referred for VAPHS cardiac rehabilitation
  • Self-reported sleep disturbance or sleep-related impairment, determined by PROMIS Sleep Disturbance T-score at least 55 (raw score at least 25) or PROMIS Sleep-Related Impairment T-score at least 55 (raw score at least 20)
  • English language fluency
  • Willing and able to voluntarily participate in a behavioral sleep intervention clinical research study
  • Willing to permit study personnel access to VA EHR
  • Willing to permit study personnel to communicate with routine VA healthcare providers
  • Willing and able to participate in outpatient cardiac rehabilitation at VAPHS

You may not qualify if:

  • Moderate to severe cognitive impairment
  • Active suicidal ideation, plan, or intent
  • Current moderate to severe alcohol or substance use disorder
  • Current severe symptoms of depression, anxiety, mania/hypomania, psychosis, or PTSD
  • Currently engaged in a non-pharmacological intervention for sleep
  • Currently working night shifts
  • Currently pregnant and/or breast-feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

Pittsburgh, Pennsylvania, 15240, United States

Location

MeSH Terms

Conditions

Sleep Wake DisordersParasomnias

Interventions

AcclimatizationCardiac Rehabilitation

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Intervention Hierarchy (Ancestors)

Adaptation, PhysiologicalPhysiological PhenomenaAdaptation, BiologicalBiological PhenomenaRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Caitlan A. Tighe, PhD MA

    VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pilot randomized trial with participants assigned to one of two groups in parallel for the duration of the study.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2020

First Posted

August 10, 2020

Study Start

January 27, 2022

Primary Completion

April 16, 2023

Study Completion

April 16, 2023

Last Updated

May 10, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will share

Final data sets underlying publications resulting from the proposed research may be shared.

Time Frame
Prior to the end of the study.
Access Criteria
A Limited Dataset (LDS) may be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset.

Locations